검색어 : 통합검색[Anderson Denise G..]
총 146건 중 146건 출력
, 12/15 페이지
-
111
- Role of Lymphovascular Invasion in Pattern C Invasive Endocervical Adenocarcinoma
- Roma, Andres A.; Park, Kay J.; Xie, Hao; De Vivar, Andrea D.; Alvarado-Cabrero, Isabel; Rutgers, Joanne K.L.; Barbuto, Denise; Silva, Elvio G.; *Department of Anatomic Pathology, University of California San Diego, San Diego ¶Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA †Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY ‡Department of Internal Medicine, Yale University School of Medicine, New Haven, CT §Brown and Associates Medical Laboratories, L.L.P. #Department of Pathology, MD Anderson Cancer Center, University of Texas, Houston, TX ∥Department of Pathology, Mexican Oncology Hospital, Mexico City, Mexico; (The American journal of surgical pathology, v.41, 2017, pp.1205-1211)
-
112
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- Chugh, Rashmi; Wathen, J. Kyle; Maki, Robert G.; Benjamin, Robert S.; Patel, Shreyaskumar R.; Myers, Paul A.; Priebat, Dennis A.; Reinke, Denise K.; Thomas, Dafydd G.; Keohan, Mary L.; Samuels, Brian L.; Baker, Laurence H.; From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Memorial Sloan-Kettering Cancer Center; New York, NY; Washington Cancer Institute, Washington, DC; and Kootenai Cancer Center, Coeur d'Alene, ID.; From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Memorial Sloan-Kettering Cancer Center; New York, NY; Washington Cancer Institute, Washington, DC; and Kootenai Cancer Center, Coeur d'Alene, ID.; From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Memorial Sloan-Kettering Cancer Center; New York, NY; Washington Cancer Institute, Washington, DC; and Kootenai Cancer Center, Coeur d'Alene, ID.; From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI; The University of Texas M. D. A; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.27, 2009, pp.3148-3153)
-
113
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- Tawbi, Hussein A; Burgess, Melissa; Bolejack, Vanessa; Van Tine, Brian A; Schuetze, Scott M; Hu, James; D'Angelo, Sandra; Attia, Steven; Riedel, Richard F; Priebat, Dennis A; Movva, Sujana; Davis, Lara E; Okuno, Scott H; Reed, Damon R; Crowley, John; Butterfield, Lisa H; Salazar, Ruth; Rodriguez-Canales, Jaime; Lazar, Alexander J; Wistuba, Ignacio I; Baker, Laurence H; Maki, Robert G; Reinke, Denise; Patel, Shreyaskumar; University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Pittsburgh, Pittsburgh, PA, USA; Cancer Research and Biostatistics, Seattle, WA, USA; Washington University School of Medicine, St Louis, MO, USA; University of Michigan, Ann Arbor, MI, USA; University of Southern California, Los Angeles, CA, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Mayo Clinic, Jacksonville, FL, USA; Duke University, Durham, NC, USA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA; Fox Chase Cancer Center, Philadelphia, PA, USA; Oregon Health & Science University, Portland, OR, USA; Mayo Clinic, Jacksonville, FL, USA; Moffitt Cancer Center, Tampa, FL, USA; Cancer Research and Biostatistics, Seattle, WA, USA; University of Pittsburgh, Pittsburgh, PA, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Texas MD Anderson; (The Lancet. Oncology, v.18, 2017, pp.1493-1501)
-
114
- Invasive Endocervical Adenocarcinoma: A New Pattern-based Classification System With Important Clinical Significance
- Roma, Andres A.; Diaz De Vivar, Andrea; Park, Kay J.; Alvarado-Cabrero, Isabel; Rasty, Golnar; Chanona-Vilchis, Jose G.; Mikami, Yoshiki; Hong, Sung R.; Teramoto, Norihiro; Ali-Fehmi, Rouba; Rutgers, Joanne K.L.; Barbuto, Denise; Silva, Elvio G.; *Cleveland Clinic, Cleveland, OH †Baylor College of Medicine, Texas Children’s Hospital Pavilion for Women ∥∥The University of Texas MD Anderson Cancer Center, Houston, TX ‡Memorial Sloan Kettering Cancer Center, New York, NY ‡‡Department of Pathology, Wayne State University, Detroit, MI §§Cedars-Sinai Medical Center, Los Angeles, CA §Mexican Oncology Hospital, Mexico City, Mexico ¶Instituto Nacional de Cancerologia (Mexico), Mexico City, Mexico ∥University Health Network, University of Toronto, Toronto, ON #Kyoto University Hospital, Kyoto ††Shikoku Cancer Center, Matsuyama, Japan **Cheil General Hospital & Women’s Healthcare Center, Kwandong University, Gangneung, Korea; (The American journal of surgical pathology, v.39, 2015, pp.667-672)
-
115
- Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028.
- Burgess, Melissa Amber; Roszik, Jason; Van Tine, Brian Andrew; Hu, James; Schuetze, Scott; D'Angelo, Sandra P.; Attia, Steven; Priebat, Dennis A.; Okuno, Scott H.; Riedel, Richard F.; Davis, Lara Emily; Movva, Sujana; Reed, Damon R.; Baker, Laurence H.; Reinke, Denise K.; Maki, Robert G.; Patel, Shreyaskumar; Tawbi, Hussein Abdul-Hassan; Butterfield, Lisa Helene; University of Pittsburgh Physicians, Pittsburgh, PA; ; The University of Texas MD Anderson Cancer Center, Houston, TX; ; Washington University in St. Louis, St Louis, MO; ; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; ; University of Michigan, Ann Arbor, MI; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Mayo Clinic, Jacksonville, FL; ; Washington Hospital Center, Washington, DC; ; Mayo Clinic, Rochester, MN; ; Duke University Medical Center, Durham, NC; ; Oregon Health & Science University, Portland, OR; ; Fox Chase Cancer Ctr, Philadelphia, PA; ; Moffitt Cancer Center, Tampa, FL; ; University of Michigan, Ann Arbor, MI; ; SARC, Ann Arbor, MI; ; Icahn School of Medicine at Mount Sinai, New York, NY; ; The University of Texas MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Houston, TX; ; The University of Texas MD Anderson Cancer Center, Houston, TX; ; University of Pittsburgh Cancer Institute/Hillman Cancer Center; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.60-60)
-
116
- Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated <i>KRAS G12C+</i>advanced non-small cell lung cancer (NSCLC).
- Skoulidis, Ferdinandos; Cuppens, Kristof; Sacher, Adrian G.; Velcheti, Vamsidhar; Lee, Dae Ho; Lin, Mark T.; Fernando, Tharu M.; Li, Shuai; Bradley, Denise; Zarak Crnkovic, Martina; Mathisen, Michael; The University of Texas MD Anderson Cancer Center, Houston, TX; Jessa Hospital, Hasselt, Belgium; Princess Margaret Cancer Centre, Toronto, ON, Canada; NYU Perlmutter Cancer Center, New York, NY; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Genentech, Inc., South San Francisco, CA; Genentech, Inc., South San Francisco, CA; Genentech, Inc., South San Francisco, CA; Roche Products Ltd., Welwyn Garden City, United Kingdom; F. Hoffmann-La Roche Ltd, Basel, Switzerland; Genentech, Inc., South San Francisco, CA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.42, 2024, pp.TPS8651-TPS8651)
-
117
- HERMIONE: A Phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with chemotherapy of physician’s choice plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab and ado-trastuzumab emtansine (T-DM1).
- Miller, Kathy; Cortes, Javier; Hurvitz, Sara A.; Krop, Ian E.; Tripathy, Debu; Verma, Sunil; Riahi, Kaveh; Reynolds, Joseph G.; Wickham, Thomas J.; Molnar, Istvan; Yardley, Denise A.; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Vall D'Hebron University Hospital, Barcelona, Spain; UCLA Healthcare Hematology-Oncology Breast Oncology Program, Santa Monica, CA; Dana-Farber Cancer Institute, Boston, MA; The University of Texas MD Anderson Cancer Center, Houston, TX; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Merrimack Pharma, Cambridge, MA; Merrimack Pharmaceuticals, Inc., Cambridge, MA; Merrimack Pharmaceuticals, Inc., Cambridge, MA; Merrimack Pharmaceuticals, Inc., Cambridege, MA; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.TPS641-TPS641)
-
118
- Abstract P2-05-01: Addressing barriers to adherence and quality of life among women recommended to receive chemoprevention for breast cancer prevention
- Jones, Jessica T.; Whisenant, Meagan; Brassil, Kelly J.; Warlick, Hannah G.; Solis, Emily; Kamat, Sharvari; Maliackal, Ann; Walters, Amie; Ponce, Darcy; Gonzalez, Anneliese; Rios, Denise; Emily, Robinson; 1UT Health Houston, Houston, Texas; 2UTHealth Cizik School of Nursing, Houston, Texas; 3Pack Health, A Quest Diagnostics Company, Houston, Texas; 4The University of Texas Health Science Center at Houston, Harrisburg, North Carolina; 5The University of Texas Health Science Center at Houston, Cizik School of Nursing, Department of Research; 6UT Health; 7MD Anderson Cancer Center; 8The University of Texas Health Science Center at Houston, Cizik School of Nursing, Department of Research; 9UT Health Cizik school of Nursing, Texas; 10UT Health Houston, Houston, Texas; 11The University of Texas Health Science Center at Houston Cizik School of Nursing; 12UT Health Houston.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.P2-05-01-P2-05-01)
-
119
- Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily
- Pelser, Colleen; Vitale, Francesco; Whitby, Denise; Graubard, Barry I.; Messina, Angelo; Gafà , Lorenzo; Brown, Elizabeth E.; Anderson, Lesley A.; Romano, Nino; Lauria, Carmela; Goedert, James J.; Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland; Section of Hygiene, Department of Sciences for Health Promotion 'G. D'Alessandro', Universitá degli studi di Palermo, Palermo, Italy; Viral Oncology Section, AIDS and Cancer Virus Program, SAIC-Frederick, National Cancer Institute-Frederick, Frederick, Maryland; Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland; Dipartimento di Scienze Biomediche, Universitá degli studi di Catania, Catania, Italy; Lega Italiana per la Lotta Contro i Tumori-Sez Ragusa, Ragusa, Italy; Department of Epidemiology, Medicine and Microbiology, University of Alabama at Birmingham, Birmingham, Alabama; Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland; Section of Hygiene, Department of Sciences for Health Promotion 'G. D'Alessa; (Journal of medical virology, v.81, 2009, pp.1938-1944)
-
120
- Effects of non-invasive, 1,210 nm laser exposure on adipose tissue: Results of a human pilot study
- Wanner, Molly; Avram, Mathew; Gagnon, Denise; Mihm Jr., Martin C.; Zurakowski, David; Watanabe, Kanna; Tannous, Zeina; Anderson, R. Rox; Manstein, Dieter; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Anesthesia and Surgery, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts G; (Lasers in surgery and medicine, v.41, 2009, pp.401-407)
QUICK MENU
